At the Panacea Biotec office, conversations around DengiAll are cloaked with an air of eagerness. With the human trials ...

Pakistan has decided to pursue joint local production of vaccines included in the Expanded Programme on Immunisation (EPI) in ...

DengiAll emerges as a promising single-dose solution offering balanced protection against all four dengue types.

The Cybersecurity Imperative for Indian Pharma Manufacturing in 2025 India’s pharmaceutical manufacturing sector is a ...

India has firmly established itself as the world's major producer of generic drugs. It is currently ranked third in ...

Supporting access to the vaccine in low-and-middle-income countries (LMICs) falls within the framework of the funding agreement Valneva signed with the Coalition for Epidemic Preparedness Innovations ...

Artificial intelligence’s (AI) predictive capabilities will help the vaccine industry optimize manufacturing, reduce production costs, and increase patient access to lifesaving jabs. That, at least, ...

In response to the RTI application, DPIIT had stated that the requested information was not held by its logistics division ...

A delegation of leaders from Johns Hopkins visited four cities in India in late November, announcing university investments in programs that address national priorities for India, including ...

Doctors and industry executives say this lack of disclosure by the Central Drugs Standard Control Organisation (CDSCO) ...